Bernasocchi, Tiziano
El Tekle, Geniver http://orcid.org/0000-0003-4772-1131
Bolis, Marco
Mutti, Azzurra
Vallerga, Arianna
Brandt, Laura P.
Spriano, Filippo
Svinkina, Tanya
Zoma, Marita
Ceserani, Valentina
Rinaldi, Anna
Janouskova, Hana
Bossi, Daniela
Cavalli, Manuela
Mosole, Simone
Geiger, Roger http://orcid.org/0000-0002-8016-1669
Dong, Ze
Yang, Cai-Guang http://orcid.org/0000-0001-5778-4422
Albino, Domenico
Rinaldi, Andrea
Schraml, Peter
Linder, Simon
Carbone, Giuseppina M. http://orcid.org/0000-0003-4652-585X
Alimonti, Andrea http://orcid.org/0000-0002-9362-2313
Bertoni, Francesco
Moch, Holger
Carr, Steven A.
Zwart, Wilbert http://orcid.org/0000-0002-9823-7289
Kruithof-de Julio, Marianna http://orcid.org/0000-0002-6085-7706
Rubin, Mark A. http://orcid.org/0000-0002-8321-9950
Udeshi, Namrata D. http://orcid.org/0000-0001-5312-1402
Theurillat, Jean-Philippe P. http://orcid.org/0000-0003-0111-5937
Article History
Received: 6 July 2020
Accepted: 22 December 2020
First Online: 2 February 2021
Competing interests
: The authors declare the following competing interests, M.A.R. is listed as a co-inventor on US and International patents in the diagnostic and therapeutic fields of ETS gene fusion prostate cancers (Harvard and University of Michigan) and SPOP mutations (Weill Cornell Medicine). J.P.T. has received funding for the venue of scientific conferences from Astellas, MSD, and Janssen/Cilag. The remaining authors declare no competing financial interests.